Global Recombinant Coagulation Factors Industry Research Report 2020, Forecast to 2025

June 2020 | 102 pages | ID: GD970A9FE841EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Recombinant Coagulation Factors market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Recombinant Coagulation Factors is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Recombinant Coagulation Factors industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Recombinant Coagulation Factors by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Recombinant Coagulation Factors market are discussed.

The market is segmented by types:

• Recombinant Factor VIII
• Recombinant Factor IX
• Von Willebrand Factor

It can be also divided by applications:

• Hospitals
• Clinics
• Research Organizations

And this report covers the historical situation, present status and the future prospects of the global Recombinant Coagulation Factors market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Baxter International Inc.
• Octapharma AG
• CSL Ltd.
• Bayer AG
• Novo Nordisk A/S
• Biogen Idec
• Kedrion S.P.A.
• Grifols International SA
• Pfizer Inc.

Report Includes:

• xx data tables and xx additional tables
• An overview of global Recombinant Coagulation Factors market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Recombinant Coagulation Factors market
• Profiles of major players in the industry, including%li% Baxter International Inc.,%li% Octapharma AG,%li% CSL Ltd.,%li% Bayer AG,%li% Novo Nordisk A/S.....

Research objectives

• To study and analyze the global Recombinant Coagulation Factors consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Recombinant Coagulation Factors market by identifying its various subsegments.
• Focuses on the key global Recombinant Coagulation Factors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Recombinant Coagulation Factors with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Recombinant Coagulation Factors submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Recombinant Coagulation Factors Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Recombinant Coagulation Factors Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 RECOMBINANT COAGULATION FACTORS INDUSTRY OVERVIEW

2.1 Global Recombinant Coagulation Factors Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Recombinant Coagulation Factors Global Import Market Analysis
  2.1.2 Recombinant Coagulation Factors Global Export Market Analysis
  2.1.3 Recombinant Coagulation Factors Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Recombinant Factor VIII
  2.2.2 Recombinant Factor IX
  2.2.3 Von Willebrand Factor
2.3 Market Analysis by Application
  2.3.1 Hospitals
  2.3.2 Clinics
  2.3.3 Research Organizations
2.4 Global Recombinant Coagulation Factors Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Recombinant Coagulation Factors Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Recombinant Coagulation Factors Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Recombinant Coagulation Factors Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Recombinant Coagulation Factors Manufacturer Market Share
  2.4.5 Top 10 Recombinant Coagulation Factors Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Recombinant Coagulation Factors Market
  2.4.7 Key Manufacturers Recombinant Coagulation Factors Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Recombinant Coagulation Factors Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Recombinant Coagulation Factors Industry Impact
  2.7.1 How the Covid-19 is Affecting the Recombinant Coagulation Factors Industry
  2.7.2 Recombinant Coagulation Factors Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Recombinant Coagulation Factors Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Recombinant Coagulation Factors Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL RECOMBINANT COAGULATION FACTORS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Recombinant Coagulation Factors Sales Market Share by Region
4.2 Global Recombinant Coagulation Factors Revenue Market Share by Region (2015-2019)
4.3 Global Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Recombinant Coagulation Factors Market Size Detail
  4.4.1 North America Recombinant Coagulation Factors Sales Growth Rate (2015-2020)
  4.4.2 North America Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Recombinant Coagulation Factors Market Size Detail
  4.5.1 Europe Recombinant Coagulation Factors Sales Growth Rate (2015-2020)
  4.5.2 Europe Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Recombinant Coagulation Factors Market Size Detail
  4.6.1 Japan Recombinant Coagulation Factors Sales Growth Rate (2015-2020)
  4.6.2 Japan Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Recombinant Coagulation Factors Market Size Detail
  4.7.1 China Recombinant Coagulation Factors Sales Growth Rate (2015-2020)
  4.7.2 China Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL RECOMBINANT COAGULATION FACTORS MARKET SEGMENT BY TYPE

5.1 Global Recombinant Coagulation Factors Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Recombinant Coagulation Factors Sales and Market Share by Type (2015-2020)
  5.1.2 Global Recombinant Coagulation Factors Revenue and Market Share by Type (2015-2020)
5.2 Recombinant Factor VIII Sales Growth Rate and Price
  5.2.1 Global Recombinant Factor VIII Sales Growth Rate (2015-2020)
  5.2.2 Global Recombinant Factor VIII Price (2015-2020)
5.3 Recombinant Factor IX Sales Growth Rate and Price
  5.3.1 Global Recombinant Factor IX Sales Growth Rate (2015-2020)
  5.3.2 Global Recombinant Factor IX Price (2015-2020)
5.4 Von Willebrand Factor Sales Growth Rate and Price
  5.4.1 Global Von Willebrand Factor Sales Growth Rate (2015-2020)
  5.4.2 Global Von Willebrand Factor Price (2015-2020)

6 GLOBAL RECOMBINANT COAGULATION FACTORS MARKET SEGMENT BY APPLICATION

6.1 Global Recombinant Coagulation FactorsSales Market Share by Application (2015-2020)
6.2 Hospitals Sales Growth Rate (2015-2020)
6.3 Clinics Sales Growth Rate (2015-2020)
6.4 Research Organizations Sales Growth Rate (2015-2020)

7 GLOBAL RECOMBINANT COAGULATION FACTORS MARKET FORECAST

7.1 Global Recombinant Coagulation Factors Sales, Revenue Forecast
  7.1.1 Global Recombinant Coagulation Factors Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Recombinant Coagulation Factors Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Recombinant Coagulation Factors Price and Trend Forecast (2020-2025)
7.2 Global Recombinant Coagulation Factors Sales Forecast by Region (2020-2025)
  7.2.1 North America Recombinant Coagulation Factors Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Recombinant Coagulation Factors Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Recombinant Coagulation Factors Production, Revenue Forecast (2020-2025)
  7.2.4 China Recombinant Coagulation Factors Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF RECOMBINANT COAGULATION FACTORS INDUSTRY KEY MANUFACTURERS

8.1 Baxter International Inc.
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Baxter International Inc. Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Baxter International Inc. News
8.2 Octapharma AG
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Octapharma AG Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Octapharma AG News
8.3 CSL Ltd.
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 CSL Ltd. Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 CSL Ltd. News
8.4 Bayer AG
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Bayer AG Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Bayer AG News
8.5 Novo Nordisk A/S
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Novo Nordisk A/S Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Novo Nordisk A/S News
8.6 Biogen Idec
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Biogen Idec Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Biogen Idec News
8.7 Kedrion S.P.A.
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Kedrion S.P.A. Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Kedrion S.P.A. News
8.8 Grifols International SA
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Grifols International SA Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Grifols International SA News
8.9 Pfizer Inc.
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Pfizer Inc. Recombinant Coagulation Factors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Pfizer Inc. News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Recombinant Coagulation Factors Picture
Figure Research Programs/Design for This Report
Figure Global Recombinant Coagulation Factors Market by Regions (2019)
Table Global Market Recombinant Coagulation Factors Comparison by Regions (M USD) 2019-2025
Table Global Recombinant Coagulation Factors Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Recombinant Coagulation Factors by Type in 2019
Figure Recombinant Factor VIII Picture
Figure Recombinant Factor IX Picture
Figure Von Willebrand Factor Picture
Table Global Recombinant Coagulation Factors Sales by Application (2019-2025)
Figure Global Recombinant Coagulation Factors Sales Market Share by Application in 2019
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Organizations Picture
Table Global Recombinant Coagulation Factors Sales by Manufacturer (2018-2020)
Figure Global Recombinant Coagulation Factors Sales Market Share by Manufacturer in 2019
Table Global Recombinant Coagulation Factors Revenue by Manufacturer (2018-2020)
Figure Global Recombinant Coagulation Factors Revenue Market Share by Manufacturer in 2019
Table Global Recombinant Coagulation Factors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Recombinant Coagulation Factors Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Recombinant Coagulation Factors Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Recombinant Coagulation Factors Market
Table Key Manufacturers Recombinant Coagulation Factors Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Coagulation Factors
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Recombinant Coagulation Factors Sales (K Units) by Region (2015-2020)
Table Global Recombinant Coagulation Factors Sales Market Share by Region (2015-2019)
Figure Global Recombinant Coagulation Factors Sales Market Share by Region (2015-2019)
Figure Global Recombinant Coagulation Factors Sales Market Share by Region in 2018
Table Global Recombinant Coagulation Factors Revenue (Million US$) by Region (2015-2020)
Table Global Recombinant Coagulation Factors Revenue Market Share by Region (2015-2020)
Figure Global Recombinant Coagulation Factors Revenue Market Share by Region (2015-2020)
Figure Global Recombinant Coagulation Factors Revenue Market Share by Region in 2019
Table Global Recombinant Coagulation Factors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Recombinant Coagulation Factors Sales (K Units) Growth Rate (2015-2020)
Table North America Recombinant Coagulation Factors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Recombinant Coagulation Factors Sales (K Units) Growth Rate (2015-2020)
Table Europe Recombinant Coagulation Factors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Recombinant Coagulation Factors Sales (K Units) Growth Rate (2015-2020)
Table Japan Recombinant Coagulation Factors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Recombinant Coagulation Factors Sales (K Units) Growth Rate (2015-2020)
Table China Recombinant Coagulation Factors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Recombinant Coagulation Factors Sales by Type (2015-2020)
Table Global Recombinant Coagulation Factors Sales Market Share by Type (2015-2020)
Figure Global Recombinant Coagulation Factors Sales Market Share by Type in 2019
Table Global Recombinant Coagulation Factors Revenue by Type (2015-2020)
Table Global Recombinant Coagulation Factors Revenue Market Share by Type (2015-2020)
Figure Global Recombinant Coagulation Factors Revenue Market Share by Type in 2019
Figure Global Recombinant Factor VIII Sales Growth Rate (2015-2020)
Figure Global Recombinant Factor VIII Price (2015-2020)
Figure Global Recombinant Factor IX Sales Growth Rate (2015-2020)
Figure Global Recombinant Factor IX Price (2015-2020)
Figure Global Von Willebrand Factor Sales Growth Rate (2015-2020)
Figure Global Von Willebrand Factor Price (2015-2020)
Table Global Recombinant Coagulation Factors Sales by Application (2015-2020)
Table Global Recombinant Coagulation Factors Sales Market Share by Application (2015-2020)
Figure Global Recombinant Coagulation Factors Sales Market Share by Application in 2019
Figure Global Hospitals Sales Growth Rate (2015-2020)
Figure Global Clinics Sales Growth Rate (2015-2020)
Figure Global Research Organizations Sales Growth Rate (2015-2020)
Figure Global Recombinant Coagulation Factors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Recombinant Coagulation Factors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Recombinant Coagulation Factors Price and Trend Forecast (2020-2025)
Table Global Recombinant Coagulation Factors Sales (K Units) Forecast by Region (2020-2025)
Figure Global Recombinant Coagulation Factors Production Market Share Forecast by Region (2020-2025)
Figure North America Recombinant Coagulation Factors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Recombinant Coagulation Factors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Recombinant Coagulation Factors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Recombinant Coagulation Factors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Recombinant Coagulation Factors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Recombinant Coagulation Factors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Recombinant Coagulation Factors Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Recombinant Coagulation Factors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Baxter International Inc. Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Baxter International Inc.
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Baxter International Inc. Recombinant Coagulation Factors Market Share (2018-2020)
Table Baxter International Inc. Main Business
Table Baxter International Inc. Recent Development
Table Octapharma AG Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Octapharma AG
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Octapharma AG Recombinant Coagulation Factors Market Share (2018-2020)
Table Octapharma AG Main Business
Table Octapharma AG Recent Development
Table CSL Ltd. Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of CSL Ltd.
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure CSL Ltd. Recombinant Coagulation Factors Market Share (2018-2020)
Table CSL Ltd. Main Business
Table CSL Ltd. Recent Development
Table Bayer AG Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Bayer AG
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer AG Recombinant Coagulation Factors Market Share (2018-2020)
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Novo Nordisk A/S Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Novo Nordisk A/S
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novo Nordisk A/S Recombinant Coagulation Factors Market Share (2018-2020)
Table Novo Nordisk A/S Main Business
Table Novo Nordisk A/S Recent Development
Table Biogen Idec Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Biogen Idec
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biogen Idec Recombinant Coagulation Factors Market Share (2018-2020)
Table Biogen Idec Main Business
Table Biogen Idec Recent Development
Table Kedrion S.P.A. Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Kedrion S.P.A.
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Kedrion S.P.A. Recombinant Coagulation Factors Market Share (2018-2020)
Table Kedrion S.P.A. Main Business
Table Kedrion S.P.A. Recent Development
Table Grifols International SA Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Grifols International SA
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Grifols International SA Recombinant Coagulation Factors Market Share (2018-2020)
Table Grifols International SA Main Business
Table Grifols International SA Recent Development
Table Pfizer Inc. Company Profile
Figure Recombinant Coagulation Factors Product Picture and Specifications of Pfizer Inc.
Table Recombinant Coagulation Factors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Inc. Recombinant Coagulation Factors Market Share (2018-2020)
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table of Appendix